Valacyclovir and Plerixafor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valacyclovir (valacyclovir hydrochloride) and Plerixafor (plerixafor). Common drug interactions include ascites among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Valacyclovir and Plerixafor. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.

What is Plerixafor?

Plerixafor has active ingredients of plerixafor. eHealthMe is studying from 694 Plerixafor users. Check the latest studies of Plerixafor.

On Jul, 17, 2026

22 people who take Valacyclovir and Plerixafor together, and have interactions are studied.

Valacyclovir and Plerixafor drug interactions.

What are the common drug interactions of Valacyclovir and Plerixafor, by gender? *:

female:

Ascites (accumulation of fluid in the abdominal cavity)
Dyspnoea (difficult or laboured respiration)
Mucosal inflammation (infection of mucous membrane)
Pleural effusion (water on the lungs)
Pneumonia
Pyrexia (fever)
Stomatitis (inflammation of mucous membrane of mouth)
Breast cancer
Renal failure (kidney dysfunction)
Venoocclusive disease (small veins in the liver are obstructed)

male:

Febrile neutropenia (fever with reduced white blood cells)
Pyrexia (fever)
Stenotrophomonas infection
Myelosuppression (a decrease in the production of blood cells)
Somnolence (a state of near-sleep, a strong desire for sleep)
Staphylococcal infection (an infection with staphylococcus bacteria)
Body temperature increased
Diarrhoea
Escherichia infection (bacterial infection by escherichia coli)
Frequent bowel movements

What are the common drug interactions of Valacyclovir and Plerixafor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
Stenotrophomonas infection
Somnolence (a state of near-sleep, a strong desire for sleep)

10-19:

n/a

20-29:

n/a

30-39:

Ascites (accumulation of fluid in the abdominal cavity)
Dyspnoea (difficult or laboured respiration)
Mucosal inflammation (infection of mucous membrane)
Pleural effusion (water on the lungs)
Pneumonia
Pyrexia (fever)
Stomatitis (inflammation of mucous membrane of mouth)
Renal failure (kidney dysfunction)
Venoocclusive disease (small veins in the liver are obstructed)
Acute myocardial infarction (acute heart attack)

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Frequent bowel movements
Hypotension (abnormally low blood pressure)
Leukopenia (less number of white blood cells in blood)
Pyrexia (fever)
Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Body temperature increased
Diarrhoea
Escherichia infection (bacterial infection by escherichia coli)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Myelosuppression (a decrease in the production of blood cells)
Pyrexia (fever)

60+:

Breast cancer
Staphylococcal bacteraemia (a bacterial infection of blood)
Febrile neutropenia (fever with reduced white blood cells)
Staphylococcal infection (an infection with staphylococcus bacteria)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 45.45%
Adverse Event: 5 people, 22.73%
Haematopoietic Stem Cell Mobilisation: 5 people, 22.73%
High Blood Pressure: 4 people, 18.18%
Diarrhea: 4 people, 18.18%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 13.64%
Back Pain: 3 people, 13.64%
Conjunctivitis (pink eye): 3 people, 13.64%
Constipation: 3 people, 13.64%
Diabetes: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Valacyclovir and Plerixafor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously